Payment overview · 2025
General Payments
$7,414.92
48 reported records · 3 companies
Healthcare provider profile · identity verified
Eric J Houchin, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · KALAMAZOO, MI · NPI 1174522957
Verified facts
What the public records show
CMS Open Payments records show Eric J Houchin, M.D. received $7,414.92 in general payments during 2025 across 48 reported records.
Alkermes, Inc. accounted for 93.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 147 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $6,950.14 | 93.7% | 8 | 2025 |
| Braeburn Inc. | Unresolved — no canonical attribution shown | $254.94 | 3.4% | 28 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $209.84 | 2.8% | 12 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,760.00 | 2 |
| Consulting Fee | $900.00 | 1 |
| Food and Beverage | $712.42 | 42 |
| Travel and Lodging | $42.50 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $6,950.14 | 8 | 2025 |
Source payment records
|
|||||
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $254.94 | 28 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $106.73 | 6 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $106.73 | 6 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $103.11 | 6 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 147 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
147 | 29 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 598 | 129 |
| Atorvastatin Calcium | Atorvastatin Calcium | 579 | 146 |
| Gabapentin | Gabapentin | 428 | 76 |
| Omeprazole | Omeprazole | 386 | 91 |
| Alprazolam | Alprazolam | 355 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 316 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 305 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 293 | 65 |
| Lisinopril | Lisinopril | 260 | 69 |
| Furosemide | Furosemide | 248 | 58 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 246 | 29 |
| Pantoprazole Sodium | Pantoprazole Sodium | 227 | 52 |
| Amlodipine Besylate | Amlodipine Besylate | 225 | 61 |
| Metformin Hcl | Metformin Hcl | 222 | 50 |
| Losartan Potassium | Losartan Potassium | 191 | 51 |
| Pregabalin | Pregabalin | 187 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 179 | 38 |
| Sertraline Hcl | Sertraline Hcl | 179 | 33 |
| Mirtazapine | Mirtazapine | 176 | 46 |
| Metformin Hcl Er | Metformin Hcl | 163 | 51 |
| Bupropion Xl | Bupropion Hcl | 161 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 160 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 154 | 44 |
| Ozempic | Semaglutide | 147 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 142 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 136 | 47 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 135 | 31 |
| Trazodone Hcl | Trazodone Hcl | 135 | 33 |
| Potassium Chloride | Potassium Chloride | 131 | 36 |
| Tramadol Hcl | Tramadol Hcl | 127 | 21 |
| Prednisone | Prednisone | 126 | 69 |
| Carvedilol | Carvedilol | 125 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 123 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 119 | 23 |
| Eliquis | Apixaban | 116 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 115 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 112 | 20 |
| Clonazepam | Clonazepam | 110 | 17 |
| Simvastatin | Simvastatin | 107 | 30 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 101 | 21 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 99 | 13 |
| Fentanyl | Fentanyl | 98 | suppressed |
| Azithromycin | Azithromycin | 95 | 87 |
| Ondansetron Odt | Ondansetron | 95 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 94 | 25 |
| Ibuprofen | Ibuprofen | 88 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 86 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 25 |
| Meloxicam | Meloxicam | 81 | 23 |
| Diclofenac Sodium Er | Diclofenac Sodium | 80 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 78 | 21 |
| Buprenorphine Hcl | Buprenorphine Hcl | 76 | 12 |
| Glimepiride | Glimepiride | 76 | 18 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 76 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 75 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 17 |
| Montelukast Sodium | Montelukast Sodium | 73 | 17 |
| Alendronate Sodium | Alendronate Sodium | 72 | 16 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 71 | 13 |
| Finasteride | Finasteride | 71 | 21 |
| Celecoxib | Celecoxib | 70 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 68 | 17 |
| Spironolactone | Spironolactone | 68 | 15 |
| Torsemide | Torsemide | 67 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 66 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | 13 |
| Farxiga | Dapagliflozin Propanediol | 64 | 15 |
| Atenolol | Atenolol | 63 | 11 |
| Diazepam | Diazepam | 62 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 62 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 62 | 14 |
| Topiramate | Topiramate | 62 | 11 |
| Lamotrigine | Lamotrigine | 61 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | 16 |
| Famotidine | Famotidine | 59 | 16 |
| Methadone Hcl | Methadone Hcl | 58 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 57 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 56 | 22 |
| Baclofen | Baclofen | 54 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 53 | suppressed |
| Valsartan | Valsartan | 51 | 11 |
| Memantine Hcl | Memantine Hcl | 50 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 49 | 11 |
| Ezetimibe | Ezetimibe | 49 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 49 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 48 | 40 |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 17 |
| Allopurinol | Allopurinol | 47 | 13 |
| Atovaquone-Proguanil Hcl | Atovaquone/Proguanil Hcl | 47 | 47 |
| Lorazepam | Lorazepam | 47 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 41 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 40 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | 11 |
| Linzess | Linaclotide | 39 | 12 |
| Promethazine Hcl | Promethazine Hcl | 39 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 30 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Ramipril | Ramipril | 38 | suppressed |
| Risperidone | Risperidone | 38 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 36 | 14 |
| Bumetanide | Bumetanide | 36 | suppressed |
| Fluconazole | Fluconazole | 36 | 17 |
| Mounjaro | Tirzepatide | 36 | suppressed |
| Repatha Sureclick | Evolocumab | 36 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 36 | 12 |
| Fenofibrate | Fenofibrate | 34 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 33 | 16 |
| Lansoprazole | Lansoprazole | 32 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 28 |
| Cephalexin | Cephalexin | 30 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 30 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 20 |
| Bupropion Hcl | Bupropion Hcl | 28 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 28 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 28 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Ketoconazole | Ketoconazole | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 25 | 11 |
| Armour Thyroid | Thyroid,pork | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | 12 |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 22 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 22 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 22 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | 14 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Roflumilast | Roflumilast | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | 11 |
| Cefdinir | Cefdinir | 19 | 15 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Telmisartan | Telmisartan | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 14 |
| Dexlansoprazole Dr | Dexlansoprazole | 18 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Jantoven | Warfarin Sodium | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 12 |
| Methylprednisolone | Methylprednisolone | 18 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 18 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 14 |
| Nystatin | Nystatin | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Sumatriptan | Sumatriptan | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Premarin | Estrogens, Conjugated | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Belsomra | Suvorexant | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Buprenorphine | Buprenorphine | 15 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Tadalafil | Tadalafil | 13 | suppressed |
| Teriparatide | Teriparatide | 13 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 12 | suppressed |
| Zaleplon | Zaleplon | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Ingrezza | Valbenazine Tosylate | 11 | suppressed |
| Methylphenidate Hcl Cd | Methylphenidate Hcl | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Sublocade | Buprenorphine | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $7,414.92 · 48 records | Alkermes, Inc. | BRIXADI, Ozempic, Rybelsus, VIVITROL, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error